What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Understanding retirement savings in your 50s is vital for effective planning. Learn key strategies to prepare for a secure retirement.
18,168 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
SpaceX faces another setback as a Starship test ends without a successful launch. This article breaks down the implic...
Two power players, two paths: Constellation Energy and Vistra offer differing mixes of stability and upside. This gui...
Nvidia’s Feb 25 earnings print could set the stock’s direction for months. This preview breaks down the numbers to wa...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
MercadoLibre fell in February amid margin concerns and tougher competition in LATAM. This article breaks down the for...
A universal technical institute director recently sold 10,000 shares, sparking questions about what it means for UTI ...
e.l.f. beauty shares down have caught the attention of investors as momentum slows and margins feel pressure. This ar...
Braze stock surged today as the marketing-tech player highlighted AI-driven growth and stronger customer engagement m...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...